Novartis stock: buy or sell

NVS stock price: $95.63 1.07% At close on Jan 15th, 2021

Updated on:
Jan 16th, 2021

2

Novartis stock brief

  • Novartis inched a 1.07% after making new all-time highs on Friday
  • Deutsche Bank Aktiengesellschaft posted a strong buy rating for Novartis on Friday
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. Its Innovative Medicines segment offers prescription medicines for patients and healthcare providers.

Should I buy Novartis stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $NVS stock a buy?

Currently, Novartis stock matches 2 trading strategies:

Uptrend buy setup

Novartis stock is in an uptrend since last October that so far has marked a gorgeous 24.00% gain. Price marked a pull back in this uptrend at $87.41 in mid-December, and since then it bounced off a 9.40%. Price just broke out above the entry point at $92.70, but it can be traded. If price climbs above $97.34, it would be better to wait to another pullback. If you decide to enter this trade, the suggested stop loss is at $84.79

Buy setupBuy pointStop lossRisk
Uptrend buy setup$92.70$84.798.54%

ATH buy setup

One of the most recommended trading strategies is to buy on All-time Highs (ATH) breakouts. The good point of buying at all-time highs is that price doesn't have upper resistances, and usually it rises quickly. However, there's the risk of a bulls trap that may trigger your buy order and then drops sharply. That's why a stop loss is so important. Price is now at 0.95% of all-time highs and it can breakout at any time, so if you want to trade this setup it's recommended to setup your order at $96.54. The stop loss would be placed at $86.89

Buy setupBuy pointStop lossRisk
ATH buy setup$96.54$86.8910.00%

Should I sell Novartis stock?

When you own a stock with some profit, it's really hard to decide the correct moment to sell and get your benefits. Trading strategies give us the ability us to avoid rash decisions based on our personal sentiments or the buzz that surrounds the market. We like very simple setups to guide us on when is the best moment to sell a stock. Be aware that these setups are not intended for selling short $NVS stock

As a rule of thumb, you should never mantain a trade that shows a greater losses than those expected by the time of the buy. The timing to sell shares should always be determined by the stop-loss (automatic or manual)

Is it time to sell Novartis stock?

In the current situation of Novartis there is not any eligible sell setup, so Novartis stock holders with operations in green can keep their positions

Novartis ratings

In the last 30 days, 2 ratings were published for Novartis. General sentiment is bullish, with 2 out of 2 publishing positive forecasts

Novartis analysts' ratings - Last month
Brokerage firmRating
Jan 8th, 2021
Morgan Stanley Buy
Jan 15th, 2021
Deutsche Bank Aktiengesellschaft Strong buy

Novartis stock analysis

Since last October, Novartis has been drawing an uptrend that by now marked an amazing 24.13%. Rising highs and lows can be seen easily on a chart and how price action gave very few buy points on the breakouts. Latest pullback was in mid-December, when price bounced at $87.41. In late December, Novartis broke out above its last top ($92.70) giving a good buy point

$NVS at All-time Highs

On Friday, Novartis reached all-time highs (ATH) again at $96.54. Previous highs were in February 2020

SMAs overview

NVS stock SMAs chart

Supports and resistances

The current resistance levels are:

  • R1: $96.34 (0.74% above)
  • The current support levels are:

  • S1: $92.70 (-3.06% below)
  • S2: $92.31 (-3.47% below)
  • S3: $92.27 (-3.51% below)
  • Bollinger bands

    The price is trading very close to the upper Bollinger band, poiting some level of overbought in recent sessions. This is not a sell signal, as price can trade in these levels for many days and weeks

    NVS stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 in mid-December after just crossing to the overbough zone for just one day (weak signal). The RSI reading on Friday was 65.94. Novartis shares exploded a 3.25% since that level was lost

    NVS stock RSI chart

    Novartis stock price history

    Novartis started trading on Nov 7th, 1996 priced at $13.00 per share1. Since then, NVS stock has risen by 635.62%, with an average of 26.48% per year. An investment of $1,000USD on the IPO would have a value of $7,356.15 nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    NVS stock price history chart

    Price target for Novartis stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis predicting how a particular stock will performance in the future.

    The following table shows the price forecasts posted by financial institutions over the last 30 days. If you are a small trader you should not invest based on these projections.

    We don't have any target price posted in the last 4 weeks for Novartis.

    Novartis stock price predictions
    Brokerage firmPrice target
    Jan 8th, 2021
    Morgan Stanley Not available
    Jan 15th, 2021
    Deutsche Bank Aktiengesellschaft Not available

    Earnings and financials

    Earnings call was hosted by Novartis ($NVS) last October after posting the financial report. Novartis posted earnings of $1.52 per share on revenue of $12.3 billion. The market estimate was $1.45 per share on revenue of $12.5 billion.

    Same quarter last year, reported EPS was $1.41, so current EPS is an improvement of 7.80%. Sales only moved on an annualized basis in the , from $124.8B to $125.4B last quarter.

    Novartis ($NVS) is presenting Q4 financial report on January 27.

    Novartis performance

    NVS performance compared
    Company1m3m6m
    Novartis ($NVS) 5.10% 11.20% 7.90%

    Please read:
    The opinions expressed in this post are personal and not recommendations for you to buy or sell shares. The author of this article does not have an understanding of the individual circumstances of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are provided for informational motives only

    Novartis summary

    Friday, January 15th, 2021
    Open$95.61
    Close$95.63
    Day range$95.42 - $96.54
    Previous close$94.62
    Session gain1.07%
    Average true range$1.86
    50d mov avg$89.95
    100d mov avg$88.16
    200d mov avg$87.14
    Earnings dateJanuary 27th, 2021

    Frequently asked questions

    What is Novartis stock symbol?

    Novartis AG is a public company trading in the US stock market with the NVS symbol

    Is Novartis stock a buy or sell?

    Novartis received 2 ratings in the last 30 days: 2 bullish, 0 bearish and 0 neutral.

    Will NVS go up?

    There were no price targets published by market analysts in the last 4 weeks for Novartis.